(C) 2024 Electronic News Publishing, source
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
775,000 KRW | +0.65% | -3.37% | +1.97% |
Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
Apr. 25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.97% | 40.1B | |
-3.45% | 87.17B | |
+57.60% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
+7.72% | 8.81B | |
-10.53% | 8.24B | |
+0.95% | 7.62B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Life Science Fund Invests in BrickBio